 Duncan Wilcox
Concepts (516)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder | 25 | 2023 | 168 | 5.170 |
Why?
| | Cloaca | 16 | 2023 | 48 | 3.610 |
Why?
| | Urologic Surgical Procedures | 16 | 2022 | 94 | 3.110 |
Why?
| | Hypospadias | 7 | 2022 | 26 | 3.040 |
Why?
| | Urinary Bladder Neck Obstruction | 5 | 2023 | 20 | 2.470 |
Why?
| | Urogenital Abnormalities | 9 | 2023 | 49 | 2.380 |
Why?
| | Lower Urinary Tract Symptoms | 5 | 2021 | 48 | 1.890 |
Why?
| | Anorectal Malformations | 9 | 2023 | 103 | 1.860 |
Why?
| | Urinary Bladder, Neurogenic | 5 | 2022 | 30 | 1.820 |
Why?
| | Urethra | 10 | 2020 | 49 | 1.780 |
Why?
| | Hydronephrosis | 5 | 2015 | 28 | 1.640 |
Why?
| | Urogenital System | 4 | 2023 | 18 | 1.560 |
Why?
| | Urodynamics | 5 | 2019 | 30 | 1.530 |
Why?
| | Urology | 7 | 2023 | 50 | 1.520 |
Why?
| | Ureteral Obstruction | 5 | 2022 | 58 | 1.420 |
Why?
| | Urinary Bladder, Overactive | 2 | 2021 | 20 | 1.380 |
Why?
| | Spinal Dysraphism | 6 | 2017 | 43 | 1.360 |
Why?
| | Kidney | 13 | 2023 | 1344 | 1.180 |
Why?
| | Circumcision, Male | 2 | 2019 | 17 | 1.140 |
Why?
| | Lactams, Macrocyclic | 2 | 2017 | 47 | 1.120 |
Why?
| | Benzoquinones | 2 | 2017 | 43 | 1.110 |
Why?
| | Urologic Surgical Procedures, Male | 3 | 2022 | 27 | 1.110 |
Why?
| | Infant | 47 | 2022 | 8122 | 1.090 |
Why?
| | Urinary Tract | 5 | 2016 | 39 | 1.090 |
Why?
| | Postoperative Complications | 18 | 2023 | 2198 | 1.050 |
Why?
| | Hernias, Diaphragmatic, Congenital | 15 | 1998 | 189 | 1.040 |
Why?
| | Pain, Postoperative | 4 | 2020 | 208 | 1.040 |
Why?
| | Hernia, Diaphragmatic | 13 | 2000 | 66 | 0.990 |
Why?
| | Hirschsprung Disease | 8 | 2022 | 89 | 0.920 |
Why?
| | Reoperation | 10 | 2018 | 535 | 0.920 |
Why?
| | Male | 87 | 2023 | 56663 | 0.910 |
Why?
| | Child | 58 | 2023 | 18877 | 0.910 |
Why?
| | Tocotrienols | 1 | 2023 | 4 | 0.890 |
Why?
| | Urination | 4 | 2022 | 41 | 0.890 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 2 | 2016 | 219 | 0.880 |
Why?
| | Child, Preschool | 41 | 2020 | 9323 | 0.880 |
Why?
| | Urologic Diseases | 5 | 2018 | 36 | 0.880 |
Why?
| | Postoperative Care | 3 | 2019 | 226 | 0.850 |
Why?
| | Rectum | 7 | 2023 | 152 | 0.850 |
Why?
| | Muscle, Smooth | 4 | 2017 | 151 | 0.830 |
Why?
| | Penis | 3 | 2019 | 37 | 0.810 |
Why?
| | Humans | 133 | 2023 | 117051 | 0.800 |
Why?
| | Urinary Bladder Diseases | 4 | 2022 | 19 | 0.800 |
Why?
| | Disorders of Sex Development | 2 | 2019 | 37 | 0.790 |
Why?
| | Anger | 1 | 2021 | 60 | 0.770 |
Why?
| | Kidney Pelvis | 3 | 2022 | 19 | 0.760 |
Why?
| | Urinary Incontinence | 4 | 2015 | 58 | 0.760 |
Why?
| | Receptor, Serotonin, 5-HT2A | 1 | 2021 | 19 | 0.760 |
Why?
| | Anal Canal | 6 | 2023 | 83 | 0.750 |
Why?
| | Cystostomy | 3 | 2017 | 8 | 0.750 |
Why?
| | TRPV Cation Channels | 1 | 2021 | 29 | 0.750 |
Why?
| | Constipation | 1 | 2021 | 76 | 0.720 |
Why?
| | Calcium Channels | 1 | 2021 | 148 | 0.710 |
Why?
| | Retrospective Studies | 43 | 2023 | 12825 | 0.700 |
Why?
| | Female | 80 | 2023 | 60634 | 0.690 |
Why?
| | Follow-Up Studies | 23 | 2018 | 4507 | 0.690 |
Why?
| | Ureter | 5 | 2019 | 31 | 0.660 |
Why?
| | Receptors, Purinergic P2X1 | 1 | 2018 | 3 | 0.650 |
Why?
| | Cholinergic Fibers | 1 | 2018 | 17 | 0.650 |
Why?
| | Receptors, Muscarinic | 1 | 2018 | 18 | 0.640 |
Why?
| | Cryptorchidism | 4 | 2023 | 12 | 0.640 |
Why?
| | Photography | 1 | 2019 | 92 | 0.640 |
Why?
| | Intestine, Large | 1 | 2018 | 15 | 0.640 |
Why?
| | Laparoscopy | 6 | 2022 | 401 | 0.630 |
Why?
| | Genitalia, Female | 2 | 2018 | 38 | 0.630 |
Why?
| | Vesico-Ureteral Reflux | 4 | 2012 | 22 | 0.620 |
Why?
| | Muscle Contraction | 2 | 2019 | 406 | 0.620 |
Why?
| | Vagina | 3 | 2023 | 148 | 0.600 |
Why?
| | Perioperative Care | 2 | 2018 | 129 | 0.600 |
Why?
| | Fecal Incontinence | 5 | 2018 | 75 | 0.590 |
Why?
| | Preoperative Care | 3 | 2011 | 324 | 0.590 |
Why?
| | Urination Disorders | 2 | 2015 | 11 | 0.590 |
Why?
| | Anesthetics, Local | 2 | 2015 | 89 | 0.590 |
Why?
| | Pulmonary Surfactants | 9 | 2000 | 98 | 0.580 |
Why?
| | Treatment Outcome | 23 | 2022 | 9257 | 0.580 |
Why?
| | Infant, Newborn | 28 | 2020 | 5170 | 0.540 |
Why?
| | Clitoris | 1 | 2016 | 9 | 0.540 |
Why?
| | Intermittent Urethral Catheterization | 1 | 2015 | 3 | 0.520 |
Why?
| | Ultrasonography, Prenatal | 7 | 2014 | 232 | 0.510 |
Why?
| | Ventriculoperitoneal Shunt | 2 | 2011 | 30 | 0.500 |
Why?
| | Nephrectomy | 5 | 2009 | 159 | 0.480 |
Why?
| | Gastrointestinal Diseases | 1 | 2016 | 186 | 0.480 |
Why?
| | Colon | 4 | 2023 | 235 | 0.470 |
Why?
| | Infusion Pumps | 1 | 2013 | 32 | 0.470 |
Why?
| | Recovery of Function | 1 | 2018 | 590 | 0.470 |
Why?
| | Prospective Studies | 14 | 2023 | 6389 | 0.460 |
Why?
| | Creatinine | 1 | 2015 | 481 | 0.450 |
Why?
| | Animals | 29 | 2023 | 32737 | 0.450 |
Why?
| | Enema | 2 | 2006 | 39 | 0.430 |
Why?
| | Cadherins | 1 | 2014 | 180 | 0.430 |
Why?
| | Paraphimosis | 1 | 2012 | 1 | 0.430 |
Why?
| | Abnormalities, Multiple | 5 | 2006 | 178 | 0.420 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 244 | 0.420 |
Why?
| | Pediatrics | 3 | 2017 | 979 | 0.420 |
Why?
| | Bandages | 1 | 2012 | 34 | 0.410 |
Why?
| | Diagnostic Techniques, Urological | 1 | 2012 | 5 | 0.410 |
Why?
| | Analgesics, Opioid | 2 | 2020 | 792 | 0.410 |
Why?
| | Radioisotope Renography | 1 | 2011 | 4 | 0.400 |
Why?
| | Age Factors | 9 | 2019 | 2951 | 0.400 |
Why?
| | Edema | 1 | 2012 | 119 | 0.400 |
Why?
| | Surgical Sponges | 1 | 2011 | 2 | 0.390 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 4839 | 0.380 |
Why?
| | Guideline Adherence | 1 | 2015 | 502 | 0.380 |
Why?
| | Adolescent | 35 | 2023 | 18214 | 0.380 |
Why?
| | Stents | 1 | 2014 | 473 | 0.380 |
Why?
| | Dissection | 1 | 2011 | 53 | 0.380 |
Why?
| | Incidence | 6 | 2023 | 2377 | 0.370 |
Why?
| | Transition to Adult Care | 2 | 2023 | 58 | 0.370 |
Why?
| | Disease Models, Animal | 10 | 2018 | 3648 | 0.360 |
Why?
| | Registries | 1 | 2018 | 1788 | 0.360 |
Why?
| | Neurosurgical Procedures | 1 | 2011 | 157 | 0.350 |
Why?
| | Fetal Diseases | 3 | 2007 | 148 | 0.350 |
Why?
| | Bladder Exstrophy | 5 | 2007 | 16 | 0.340 |
Why?
| | Wilms Tumor | 3 | 2017 | 68 | 0.340 |
Why?
| | Sexual Dysfunction, Physiological | 2 | 2009 | 60 | 0.340 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2015 | 572 | 0.340 |
Why?
| | Cystitis | 1 | 2009 | 20 | 0.340 |
Why?
| | Doxorubicin | 2 | 2021 | 294 | 0.330 |
Why?
| | Urethral Diseases | 3 | 2020 | 18 | 0.320 |
Why?
| | Surgical Wound Infection | 1 | 2011 | 255 | 0.320 |
Why?
| | Signal Transduction | 2 | 2021 | 4606 | 0.320 |
Why?
| | Ileum | 2 | 2006 | 100 | 0.320 |
Why?
| | Adrenal Hyperplasia, Congenital | 2 | 2005 | 29 | 0.320 |
Why?
| | Mice | 12 | 2023 | 15309 | 0.320 |
Why?
| | Vascular Endothelial Growth Factor A | 3 | 2011 | 512 | 0.310 |
Why?
| | Ureterocele | 1 | 2007 | 7 | 0.310 |
Why?
| | Digestive System Abnormalities | 2 | 2004 | 11 | 0.310 |
Why?
| | Pulmonary Gas Exchange | 4 | 1998 | 112 | 0.300 |
Why?
| | Robotic Surgical Procedures | 2 | 2022 | 94 | 0.300 |
Why?
| | Prenatal Diagnosis | 5 | 2007 | 166 | 0.300 |
Why?
| | Colon, Sigmoid | 5 | 2021 | 15 | 0.290 |
Why?
| | Cathartics | 1 | 2006 | 11 | 0.290 |
Why?
| | Urography | 1 | 2006 | 13 | 0.290 |
Why?
| | Urinary Bladder Fistula | 2 | 2022 | 10 | 0.280 |
Why?
| | Congenital Abnormalities | 3 | 2020 | 73 | 0.280 |
Why?
| | Vesicovaginal Fistula | 1 | 2005 | 3 | 0.270 |
Why?
| | Colorectal Neoplasms | 2 | 2022 | 630 | 0.260 |
Why?
| | Kidney Function Tests | 4 | 2015 | 160 | 0.260 |
Why?
| | Animals, Newborn | 6 | 2018 | 797 | 0.250 |
Why?
| | Hemorrhage | 1 | 2009 | 602 | 0.250 |
Why?
| | Mass Screening | 1 | 2012 | 1034 | 0.250 |
Why?
| | Kidney Neoplasms | 2 | 2009 | 335 | 0.250 |
Why?
| | Vincristine | 2 | 2022 | 98 | 0.240 |
Why?
| | Postnatal Care | 2 | 2015 | 67 | 0.240 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2004 | 53 | 0.240 |
Why?
| | Psychosocial Support Systems | 1 | 2023 | 12 | 0.230 |
Why?
| | Prognosis | 5 | 2018 | 3390 | 0.230 |
Why?
| | Peripheral Nervous System Diseases | 2 | 2022 | 121 | 0.230 |
Why?
| | Length of Stay | 5 | 2023 | 989 | 0.230 |
Why?
| | Fetus | 1 | 2007 | 703 | 0.220 |
Why?
| | Imaging, Three-Dimensional | 1 | 2006 | 497 | 0.220 |
Why?
| | Lung | 6 | 1998 | 3588 | 0.210 |
Why?
| | Urinary Diversion | 3 | 2015 | 11 | 0.210 |
Why?
| | Sacrum | 1 | 2003 | 67 | 0.210 |
Why?
| | Surgical Flaps | 1 | 2003 | 121 | 0.210 |
Why?
| | Ultrasonography | 4 | 2015 | 671 | 0.210 |
Why?
| | Muscle Development | 1 | 2003 | 102 | 0.210 |
Why?
| | Pain Measurement | 2 | 2015 | 460 | 0.200 |
Why?
| | Kidney Calices | 1 | 2001 | 1 | 0.200 |
Why?
| | Analgesia | 2 | 2020 | 79 | 0.200 |
Why?
| | Cell Hypoxia | 3 | 2014 | 216 | 0.200 |
Why?
| | Sheep | 11 | 1998 | 763 | 0.200 |
Why?
| | Extracellular Matrix Proteins | 1 | 2003 | 130 | 0.200 |
Why?
| | Digestive System Surgical Procedures | 2 | 2019 | 89 | 0.200 |
Why?
| | Testicular Neoplasms | 2 | 2019 | 95 | 0.190 |
Why?
| | Pregnancy Outcome | 2 | 2022 | 342 | 0.190 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2020 | 10 | 0.190 |
Why?
| | Gastrostomy | 2 | 1999 | 90 | 0.190 |
Why?
| | Hydrocephalus | 2 | 2011 | 84 | 0.190 |
Why?
| | Administration, Oral | 1 | 2023 | 744 | 0.190 |
Why?
| | Robotics | 1 | 2022 | 83 | 0.190 |
Why?
| | Intestinal Obstruction | 3 | 1997 | 41 | 0.180 |
Why?
| | Colitis, Ulcerative | 2 | 2021 | 105 | 0.180 |
Why?
| | Risk Assessment | 5 | 2017 | 3021 | 0.180 |
Why?
| | Prune Belly Syndrome | 2 | 2011 | 7 | 0.180 |
Why?
| | Orchiopexy | 1 | 2019 | 5 | 0.180 |
Why?
| | Perinatology | 1 | 1999 | 5 | 0.180 |
Why?
| | Cell Division | 1 | 2002 | 767 | 0.180 |
Why?
| | Hypertrophy | 2 | 2019 | 122 | 0.170 |
Why?
| | Smooth Muscle Myosins | 1 | 2019 | 8 | 0.170 |
Why?
| | Nephrology Nursing | 1 | 2019 | 5 | 0.170 |
Why?
| | Muscle Relaxation | 1 | 2019 | 28 | 0.170 |
Why?
| | Atlases as Topic | 1 | 2019 | 9 | 0.170 |
Why?
| | Nephrostomy, Percutaneous | 1 | 1999 | 9 | 0.170 |
Why?
| | Myosin Light Chains | 1 | 2019 | 34 | 0.170 |
Why?
| | Nephrology | 1 | 1999 | 52 | 0.170 |
Why?
| | Diet | 1 | 2006 | 1128 | 0.170 |
Why?
| | Extracellular Matrix | 1 | 2003 | 446 | 0.170 |
Why?
| | Pediatric Nursing | 1 | 2019 | 39 | 0.160 |
Why?
| | Anxiety, Separation | 1 | 2018 | 17 | 0.160 |
Why?
| | Maternal Deprivation | 1 | 2018 | 14 | 0.160 |
Why?
| | Umbilicus | 1 | 1998 | 15 | 0.160 |
Why?
| | Pilot Projects | 2 | 2023 | 1394 | 0.160 |
Why?
| | Twins, Conjoined | 1 | 1998 | 4 | 0.160 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2019 | 115 | 0.160 |
Why?
| | Sex Factors | 4 | 2017 | 1758 | 0.160 |
Why?
| | Glomerular Filtration Rate | 3 | 2015 | 686 | 0.160 |
Why?
| | Phospholipids | 2 | 1997 | 202 | 0.160 |
Why?
| | Reflex | 1 | 2018 | 64 | 0.160 |
Why?
| | Medical Errors | 1 | 2019 | 85 | 0.160 |
Why?
| | Diagnostic Errors | 1 | 2019 | 156 | 0.160 |
Why?
| | Reference Values | 2 | 2018 | 751 | 0.160 |
Why?
| | Tertiary Care Centers | 1 | 2019 | 125 | 0.160 |
Why?
| | Intestinal Pseudo-Obstruction | 2 | 1997 | 7 | 0.160 |
Why?
| | Phosphatidylcholines | 2 | 1997 | 132 | 0.150 |
Why?
| | Urinary Catheterization | 2 | 2001 | 22 | 0.150 |
Why?
| | Time Factors | 6 | 2019 | 6240 | 0.150 |
Why?
| | Case-Control Studies | 3 | 2020 | 3099 | 0.150 |
Why?
| | Kidney Diseases | 4 | 2009 | 436 | 0.150 |
Why?
| | Informed Consent | 1 | 1998 | 162 | 0.150 |
Why?
| | Genitalia, Male | 1 | 1997 | 11 | 0.150 |
Why?
| | Cancer Survivors | 1 | 2021 | 201 | 0.150 |
Why?
| | Urologic Neoplasms | 1 | 2017 | 25 | 0.150 |
Why?
| | Peptic Ulcer Perforation | 1 | 1997 | 2 | 0.150 |
Why?
| | Cholestasis, Extrahepatic | 1 | 1997 | 5 | 0.150 |
Why?
| | Peptic Ulcer Hemorrhage | 1 | 1997 | 6 | 0.150 |
Why?
| | Duodenal Ulcer | 1 | 1997 | 9 | 0.150 |
Why?
| | Algorithms | 3 | 2018 | 1505 | 0.150 |
Why?
| | Catheterization | 2 | 2013 | 158 | 0.150 |
Why?
| | Cholelithiasis | 1 | 1997 | 30 | 0.150 |
Why?
| | Health Services Needs and Demand | 1 | 2019 | 249 | 0.140 |
Why?
| | Gallstones | 1 | 1997 | 25 | 0.140 |
Why?
| | Postoperative Period | 1 | 2018 | 303 | 0.140 |
Why?
| | Gene Expression Profiling | 1 | 2023 | 1588 | 0.140 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2017 | 200 | 0.140 |
Why?
| | Vulva | 1 | 2016 | 24 | 0.130 |
Why?
| | Risk Factors | 3 | 2018 | 8873 | 0.130 |
Why?
| | Patient Safety | 1 | 2019 | 278 | 0.130 |
Why?
| | Endoscopy | 1 | 1998 | 266 | 0.130 |
Why?
| | Fluorocarbons | 1 | 1997 | 100 | 0.130 |
Why?
| | Outpatients | 1 | 2019 | 327 | 0.130 |
Why?
| | Medical Oncology | 1 | 2017 | 231 | 0.130 |
Why?
| | Adult | 14 | 2023 | 31003 | 0.130 |
Why?
| | Young Adult | 8 | 2023 | 10675 | 0.130 |
Why?
| | Phosphatidylglycerols | 1 | 1995 | 20 | 0.130 |
Why?
| | Sphingomyelins | 1 | 1995 | 28 | 0.130 |
Why?
| | Pneumothorax | 1 | 1995 | 44 | 0.130 |
Why?
| | Infusion Pumps, Implantable | 1 | 2015 | 20 | 0.130 |
Why?
| | Gynecologic Surgical Procedures | 3 | 2021 | 49 | 0.130 |
Why?
| | Toothbrushing | 1 | 1994 | 6 | 0.130 |
Why?
| | Testis | 2 | 2023 | 143 | 0.130 |
Why?
| | Lung Compliance | 2 | 1995 | 48 | 0.130 |
Why?
| | Attitude to Health | 1 | 1998 | 403 | 0.130 |
Why?
| | Amniotic Fluid | 1 | 1995 | 64 | 0.120 |
Why?
| | Bulimia | 1 | 1994 | 25 | 0.120 |
Why?
| | Desmin | 2 | 2006 | 31 | 0.120 |
Why?
| | Cell Differentiation | 1 | 2002 | 1730 | 0.120 |
Why?
| | Appendix | 3 | 2001 | 26 | 0.120 |
Why?
| | Sensitivity and Specificity | 3 | 2011 | 1740 | 0.120 |
Why?
| | Scrotum | 2 | 2007 | 25 | 0.120 |
Why?
| | Bone and Bones | 1 | 1997 | 286 | 0.120 |
Why?
| | Triiodothyronine | 1 | 1994 | 43 | 0.120 |
Why?
| | Laparotomy | 1 | 1994 | 95 | 0.120 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1458 | 0.120 |
Why?
| | Organ Size | 2 | 2014 | 459 | 0.120 |
Why?
| | Statistics, Nonparametric | 1 | 2015 | 392 | 0.120 |
Why?
| | Infusions, Intravenous | 1 | 2015 | 376 | 0.120 |
Why?
| | Meconium | 1 | 1993 | 7 | 0.120 |
Why?
| | ROC Curve | 2 | 2015 | 460 | 0.120 |
Why?
| | Anastomosis, Surgical | 5 | 2020 | 141 | 0.110 |
Why?
| | Pregnancy | 10 | 2022 | 5653 | 0.110 |
Why?
| | Phenyl Ethers | 1 | 1993 | 3 | 0.110 |
Why?
| | Respiration, Artificial | 1 | 1997 | 540 | 0.110 |
Why?
| | Foreign Bodies | 1 | 1994 | 97 | 0.110 |
Why?
| | Foreign-Body Migration | 2 | 2011 | 37 | 0.110 |
Why?
| | Logistic Models | 1 | 2018 | 1877 | 0.110 |
Why?
| | Perineum | 2 | 2019 | 27 | 0.110 |
Why?
| | Nitric Oxide | 2 | 1997 | 861 | 0.110 |
Why?
| | Foreskin | 1 | 2012 | 6 | 0.110 |
Why?
| | Syndrome | 2 | 2007 | 339 | 0.110 |
Why?
| | Fertility | 2 | 2022 | 136 | 0.110 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2014 | 171 | 0.110 |
Why?
| | Infant Food | 1 | 1993 | 63 | 0.110 |
Why?
| | Apoptosis | 1 | 2002 | 2433 | 0.110 |
Why?
| | Hydrocortisone | 1 | 1994 | 269 | 0.100 |
Why?
| | Fetal Blood | 1 | 1994 | 275 | 0.100 |
Why?
| | Comorbidity | 2 | 2016 | 1487 | 0.100 |
Why?
| | Receptor, Muscarinic M3 | 1 | 2011 | 2 | 0.100 |
Why?
| | Shock | 1 | 1993 | 76 | 0.100 |
Why?
| | Metabolism, Inborn Errors | 1 | 2011 | 38 | 0.100 |
Why?
| | Genitalia | 2 | 2019 | 28 | 0.100 |
Why?
| | Severity of Illness Index | 2 | 2016 | 2633 | 0.100 |
Why?
| | Pain Management | 1 | 2013 | 289 | 0.090 |
Why?
| | Predictive Value of Tests | 2 | 2012 | 1825 | 0.090 |
Why?
| | Parents | 1 | 1998 | 1208 | 0.090 |
Why?
| | Databases, Factual | 3 | 2019 | 1167 | 0.090 |
Why?
| | Hernia, Ventral | 1 | 2010 | 18 | 0.090 |
Why?
| | Genetic Therapy | 1 | 2011 | 266 | 0.090 |
Why?
| | Ischemia | 1 | 1993 | 368 | 0.090 |
Why?
| | Acute Disease | 1 | 2012 | 916 | 0.090 |
Why?
| | Urinary Reservoirs, Continent | 2 | 2016 | 4 | 0.080 |
Why?
| | Campomelic Dysplasia | 1 | 2009 | 2 | 0.080 |
Why?
| | Dysgerminoma | 1 | 2009 | 3 | 0.080 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 561 | 0.080 |
Why?
| | BK Virus | 1 | 2009 | 15 | 0.080 |
Why?
| | Constriction, Pathologic | 2 | 2021 | 208 | 0.080 |
Why?
| | Urolithiasis | 1 | 2009 | 8 | 0.080 |
Why?
| | Immunohistochemistry | 4 | 2011 | 1657 | 0.080 |
Why?
| | Hyperbaric Oxygenation | 1 | 2009 | 39 | 0.080 |
Why?
| | Polyomavirus Infections | 1 | 2009 | 22 | 0.080 |
Why?
| | SOX9 Transcription Factor | 1 | 2009 | 23 | 0.080 |
Why?
| | Tumor Virus Infections | 1 | 2009 | 41 | 0.080 |
Why?
| | Bronchoalveolar Lavage Fluid | 3 | 1997 | 600 | 0.080 |
Why?
| | Cohort Studies | 2 | 2016 | 5051 | 0.080 |
Why?
| | Ureterostomy | 1 | 2007 | 3 | 0.080 |
Why?
| | Disease Progression | 1 | 2015 | 2467 | 0.080 |
Why?
| | Bone Marrow Transplantation | 1 | 2009 | 244 | 0.080 |
Why?
| | Nanoparticles | 1 | 2011 | 320 | 0.080 |
Why?
| | Evidence-Based Medicine | 1 | 2012 | 682 | 0.080 |
Why?
| | Neoplasms | 1 | 2021 | 2146 | 0.070 |
Why?
| | Liver Neoplasms | 1 | 2011 | 523 | 0.070 |
Why?
| | Urogenital Neoplasms | 1 | 2006 | 4 | 0.070 |
Why?
| | Myogenin | 1 | 2006 | 13 | 0.070 |
Why?
| | Organ Culture Techniques | 1 | 2007 | 146 | 0.070 |
Why?
| | Pulmonary Artery | 4 | 1997 | 1025 | 0.070 |
Why?
| | Rhabdomyosarcoma, Embryonal | 1 | 2006 | 16 | 0.070 |
Why?
| | Calcinosis | 1 | 2009 | 256 | 0.070 |
Why?
| | Analysis of Variance | 3 | 2009 | 1239 | 0.070 |
Why?
| | Hematocolpos | 1 | 2005 | 3 | 0.070 |
Why?
| | Colonic Neoplasms | 1 | 2007 | 223 | 0.060 |
Why?
| | Fetal Organ Maturity | 2 | 1995 | 26 | 0.060 |
Why?
| | Malabsorption Syndromes | 1 | 2004 | 14 | 0.060 |
Why?
| | Defecation | 1 | 2004 | 18 | 0.060 |
Why?
| | Nutritional Support | 1 | 2004 | 27 | 0.060 |
Why?
| | Gestational Age | 3 | 2004 | 766 | 0.060 |
Why?
| | Practice Guidelines as Topic | 1 | 2012 | 1403 | 0.060 |
Why?
| | Biomarkers | 1 | 2014 | 3549 | 0.060 |
Why?
| | Ovarian Neoplasms | 1 | 2009 | 416 | 0.060 |
Why?
| | Menstruation Disturbances | 1 | 2003 | 12 | 0.060 |
Why?
| | Salvage Therapy | 1 | 2004 | 129 | 0.060 |
Why?
| | Decision Support Techniques | 1 | 2007 | 360 | 0.060 |
Why?
| | Coitus | 1 | 2003 | 28 | 0.060 |
Why?
| | Rabbits | 2 | 1996 | 762 | 0.060 |
Why?
| | Urologists | 1 | 2023 | 18 | 0.060 |
Why?
| | Surveys and Questionnaires | 3 | 2022 | 4661 | 0.060 |
Why?
| | Steroid 21-Hydroxylase | 1 | 2003 | 29 | 0.060 |
Why?
| | Extravasation of Diagnostic and Therapeutic Materials | 1 | 2003 | 14 | 0.060 |
Why?
| | Urethral Obstruction | 1 | 2003 | 9 | 0.060 |
Why?
| | Methyl Green | 1 | 2003 | 1 | 0.060 |
Why?
| | Colostomy | 3 | 2004 | 26 | 0.060 |
Why?
| | Eosine Yellowish-(YS) | 1 | 2003 | 6 | 0.060 |
Why?
| | Ascites | 1 | 2003 | 36 | 0.050 |
Why?
| | Urine | 1 | 2003 | 56 | 0.050 |
Why?
| | Azo Compounds | 1 | 2003 | 25 | 0.050 |
Why?
| | Urothelium | 1 | 2003 | 33 | 0.050 |
Why?
| | Erectile Dysfunction | 1 | 2022 | 37 | 0.050 |
Why?
| | Endocrinology | 1 | 2003 | 69 | 0.050 |
Why?
| | Puberty | 1 | 2003 | 143 | 0.050 |
Why?
| | Fatal Outcome | 2 | 2007 | 281 | 0.050 |
Why?
| | Observer Variation | 1 | 2003 | 307 | 0.050 |
Why?
| | Reproducibility of Results | 2 | 2015 | 2819 | 0.050 |
Why?
| | Mucous Membrane | 1 | 2003 | 109 | 0.050 |
Why?
| | Blood Pressure | 4 | 1997 | 1618 | 0.050 |
Why?
| | Epispadias | 1 | 2001 | 3 | 0.050 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2002 | 55 | 0.050 |
Why?
| | Dilatation, Pathologic | 2 | 2001 | 55 | 0.050 |
Why?
| | Ureteral Diseases | 1 | 2001 | 3 | 0.050 |
Why?
| | Pulmonary Surfactant-Associated Proteins | 2 | 2000 | 10 | 0.050 |
Why?
| | Proteolipids | 2 | 2000 | 28 | 0.050 |
Why?
| | Learning Curve | 1 | 2022 | 69 | 0.050 |
Why?
| | Adenocarcinoma | 1 | 2007 | 794 | 0.050 |
Why?
| | Feasibility Studies | 1 | 2023 | 750 | 0.050 |
Why?
| | Interleukin-2 | 1 | 2022 | 419 | 0.050 |
Why?
| | Urinary Fistula | 1 | 2000 | 9 | 0.050 |
Why?
| | Patient Reported Outcome Measures | 1 | 2022 | 250 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 2 | 2007 | 2403 | 0.050 |
Why?
| | Sexual Dysfunctions, Psychological | 1 | 2000 | 31 | 0.050 |
Why?
| | Radiography | 1 | 2003 | 843 | 0.050 |
Why?
| | Blotting, Western | 1 | 2003 | 1172 | 0.040 |
Why?
| | Gastric Fistula | 1 | 1999 | 4 | 0.040 |
Why?
| | Intestines | 2 | 2020 | 326 | 0.040 |
Why?
| | Jejunal Diseases | 1 | 1999 | 6 | 0.040 |
Why?
| | Intestinal Fistula | 1 | 1999 | 12 | 0.040 |
Why?
| | Actins | 1 | 2002 | 386 | 0.040 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2019 | 10 | 0.040 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 1 | 2019 | 9 | 0.040 |
Why?
| | Myosin-Light-Chain Kinase | 1 | 2019 | 26 | 0.040 |
Why?
| | Intubation, Gastrointestinal | 1 | 1999 | 54 | 0.040 |
Why?
| | Pulmonary Alveoli | 2 | 2000 | 373 | 0.040 |
Why?
| | Pelvis | 1 | 1999 | 92 | 0.040 |
Why?
| | Digestive System Diseases | 1 | 1998 | 24 | 0.040 |
Why?
| | Rectal Prolapse | 1 | 2018 | 18 | 0.040 |
Why?
| | Quality of Life | 1 | 2009 | 2374 | 0.040 |
Why?
| | Biological Variation, Population | 1 | 2018 | 21 | 0.040 |
Why?
| | Genital Diseases, Female | 1 | 2018 | 27 | 0.040 |
Why?
| | Drainage | 1 | 1999 | 152 | 0.040 |
Why?
| | Cecostomy | 1 | 1998 | 3 | 0.040 |
Why?
| | Surgical Stomas | 1 | 1998 | 6 | 0.040 |
Why?
| | Mutation | 1 | 2009 | 3420 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2003 | 648 | 0.040 |
Why?
| | Surgical Mesh | 1 | 1998 | 42 | 0.040 |
Why?
| | Sigmoid Diseases | 1 | 1997 | 9 | 0.040 |
Why?
| | Capillaries | 1 | 1998 | 100 | 0.040 |
Why?
| | Blood Gas Analysis | 1 | 1997 | 70 | 0.040 |
Why?
| | Cardiology Service, Hospital | 1 | 1997 | 28 | 0.040 |
Why?
| | Survival Analysis | 2 | 2017 | 1240 | 0.040 |
Why?
| | Ampulla of Vater | 1 | 1997 | 28 | 0.040 |
Why?
| | Rhabdomyosarcoma | 1 | 2017 | 53 | 0.040 |
Why?
| | Ileal Diseases | 1 | 1996 | 9 | 0.040 |
Why?
| | Duodenum | 1 | 1997 | 64 | 0.040 |
Why?
| | Stomach | 1 | 1997 | 100 | 0.040 |
Why?
| | Rectal Neoplasms | 2 | 1998 | 121 | 0.040 |
Why?
| | Teratoma | 1 | 2017 | 91 | 0.040 |
Why?
| | Rats | 2 | 1996 | 5172 | 0.030 |
Why?
| | Barrett Esophagus | 1 | 1999 | 151 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1183 | 0.030 |
Why?
| | Persistent Fetal Circulation Syndrome | 2 | 1995 | 132 | 0.030 |
Why?
| | Collagen | 2 | 1995 | 423 | 0.030 |
Why?
| | Operative Time | 1 | 2016 | 111 | 0.030 |
Why?
| | Umbilical Cord | 1 | 1996 | 84 | 0.030 |
Why?
| | Clinical Protocols | 1 | 1997 | 232 | 0.030 |
Why?
| | Wound Healing | 1 | 1998 | 269 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2017 | 634 | 0.030 |
Why?
| | NADPH Dehydrogenase | 1 | 1995 | 8 | 0.030 |
Why?
| | Amino Acid Oxidoreductases | 1 | 1995 | 18 | 0.030 |
Why?
| | United States | 1 | 2011 | 12380 | 0.030 |
Why?
| | Phosphorylation | 1 | 2019 | 1590 | 0.030 |
Why?
| | Middle Aged | 5 | 2021 | 27172 | 0.030 |
Why?
| | Tunica Intima | 1 | 1995 | 77 | 0.030 |
Why?
| | Proteins | 3 | 1995 | 930 | 0.030 |
Why?
| | Total Lung Capacity | 1 | 1994 | 32 | 0.030 |
Why?
| | Swine | 1 | 1996 | 714 | 0.030 |
Why?
| | Bupivacaine | 1 | 1994 | 34 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 1996 | 566 | 0.030 |
Why?
| | Thoracotomy | 1 | 1994 | 67 | 0.030 |
Why?
| | Mothers | 1 | 2020 | 682 | 0.030 |
Why?
| | Endothelins | 1 | 1994 | 62 | 0.030 |
Why?
| | Heart Diseases | 1 | 1997 | 336 | 0.030 |
Why?
| | Sigmoid Neoplasms | 1 | 1993 | 3 | 0.030 |
Why?
| | Disease Management | 1 | 2017 | 560 | 0.030 |
Why?
| | Gangrene | 1 | 1993 | 6 | 0.030 |
Why?
| | Hypertonic Solutions | 1 | 1993 | 8 | 0.030 |
Why?
| | Product Labeling | 1 | 1993 | 5 | 0.030 |
Why?
| | Ileostomy | 2 | 2004 | 18 | 0.030 |
Why?
| | Cardiac Surgical Procedures | 1 | 1997 | 443 | 0.030 |
Why?
| | Recurrence | 1 | 1995 | 967 | 0.030 |
Why?
| | INDEL Mutation | 1 | 2011 | 13 | 0.030 |
Why?
| | Necrosis | 1 | 1993 | 223 | 0.030 |
Why?
| | Frameshift Mutation | 1 | 2011 | 28 | 0.030 |
Why?
| | Colorado | 2 | 2018 | 4121 | 0.030 |
Why?
| | Consanguinity | 1 | 2011 | 49 | 0.030 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2011 | 151 | 0.030 |
Why?
| | beta-Galactosidase | 1 | 2011 | 64 | 0.020 |
Why?
| | Mice, SCID | 1 | 2011 | 328 | 0.020 |
Why?
| | Gene Transfer Techniques | 1 | 2011 | 153 | 0.020 |
Why?
| | Colitis | 1 | 1993 | 219 | 0.020 |
Why?
| | Extracorporeal Membrane Oxygenation | 3 | 2000 | 245 | 0.020 |
Why?
| | Patient Satisfaction | 1 | 2013 | 595 | 0.020 |
Why?
| | Heart Defects, Congenital | 1 | 1995 | 686 | 0.020 |
Why?
| | Tissue Survival | 1 | 2007 | 13 | 0.020 |
Why?
| | Base Sequence | 1 | 2011 | 2123 | 0.020 |
Why?
| | Chronic Disease | 1 | 1993 | 1619 | 0.020 |
Why?
| | Cystectomy | 1 | 2007 | 32 | 0.020 |
Why?
| | Likelihood Functions | 1 | 2007 | 134 | 0.020 |
Why?
| | Colectomy | 1 | 2007 | 84 | 0.020 |
Why?
| | Atrophy | 1 | 2007 | 157 | 0.020 |
Why?
| | Microsurgery | 1 | 2007 | 63 | 0.020 |
Why?
| | Vaginal Neoplasms | 1 | 2006 | 11 | 0.020 |
Why?
| | Models, Molecular | 1 | 2011 | 1405 | 0.020 |
Why?
| | Hypertension, Pulmonary | 1 | 1998 | 1771 | 0.020 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2006 | 65 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2009 | 1144 | 0.020 |
Why?
| | Hydroxyproline | 2 | 1995 | 23 | 0.020 |
Why?
| | Elastin | 2 | 1995 | 77 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2011 | 2648 | 0.020 |
Why?
| | Duodenal Obstruction | 1 | 2004 | 5 | 0.020 |
Why?
| | Short Bowel Syndrome | 1 | 2004 | 19 | 0.020 |
Why?
| | Intestinal Atresia | 1 | 2004 | 15 | 0.020 |
Why?
| | Parenteral Nutrition, Total | 1 | 2004 | 38 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 2814 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2007 | 1341 | 0.010 |
Why?
| | Enteritis | 1 | 2004 | 82 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2006 | 1063 | 0.010 |
Why?
| | Gender Identity | 1 | 2003 | 102 | 0.010 |
Why?
| | Aorta | 2 | 1995 | 358 | 0.010 |
Why?
| | Europe | 1 | 2003 | 349 | 0.010 |
Why?
| | Consensus | 1 | 2003 | 532 | 0.010 |
Why?
| | Body Weight | 1 | 2004 | 901 | 0.010 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2000 | 99 | 0.010 |
Why?
| | Societies, Medical | 1 | 2003 | 684 | 0.010 |
Why?
| | Prostatic Neoplasms | 1 | 2006 | 936 | 0.010 |
Why?
| | Glycoproteins | 1 | 2000 | 317 | 0.010 |
Why?
| | Graft Survival | 1 | 2001 | 487 | 0.010 |
Why?
| | Compartment Syndromes | 1 | 1998 | 30 | 0.010 |
Why?
| | Leiomyoma | 1 | 1998 | 45 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2006 | 3956 | 0.010 |
Why?
| | DNA | 2 | 1995 | 1372 | 0.010 |
Why?
| | Blood-Air Barrier | 1 | 1998 | 9 | 0.010 |
Why?
| | Enteral Nutrition | 1 | 1999 | 166 | 0.010 |
Why?
| | Esophagoscopy | 1 | 1999 | 189 | 0.010 |
Why?
| | Venous Thrombosis | 1 | 1998 | 145 | 0.010 |
Why?
| | Constriction | 1 | 1996 | 44 | 0.010 |
Why?
| | Kidney Failure, Chronic | 1 | 2002 | 507 | 0.010 |
Why?
| | Iatrogenic Disease | 1 | 1996 | 49 | 0.010 |
Why?
| | Hospitals, Veterans | 1 | 1997 | 239 | 0.010 |
Why?
| | Venules | 1 | 1995 | 13 | 0.010 |
Why?
| | Heart Septum | 1 | 1995 | 27 | 0.010 |
Why?
| | Arterioles | 1 | 1995 | 46 | 0.010 |
Why?
| | Pneumonia | 1 | 2000 | 575 | 0.010 |
Why?
| | Biopsy | 1 | 1999 | 1056 | 0.010 |
Why?
| | Ductus Arteriosus, Patent | 1 | 1995 | 50 | 0.010 |
Why?
| | Heart Septal Defects, Atrial | 1 | 1995 | 51 | 0.010 |
Why?
| | Heart Atria | 1 | 1995 | 110 | 0.010 |
Why?
| | Pleura | 1 | 1994 | 18 | 0.010 |
Why?
| | Nitric Oxide Synthase | 1 | 1995 | 219 | 0.010 |
Why?
| | Bronchi | 1 | 1995 | 241 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 1998 | 696 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1995 | 523 | 0.010 |
Why?
| | Administration, Inhalation | 1 | 1995 | 642 | 0.010 |
Why?
| | Hospital Mortality | 1 | 1997 | 795 | 0.010 |
Why?
| | Heparin | 1 | 1994 | 226 | 0.010 |
Why?
| | Echocardiography | 1 | 1994 | 564 | 0.010 |
Why?
| | Heart Ventricles | 1 | 1995 | 728 | 0.010 |
Why?
| | Cystic Fibrosis | 1 | 1999 | 977 | 0.010 |
Why?
| | Aged | 2 | 1997 | 19358 | 0.000 |
Why?
| | Aged, 80 and over | 1 | 1993 | 6453 | 0.000 |
Why?
|
|
Wilcox's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|